首页 › 基金 › PURA VIDA INVESTMENTS, LLC › MGX
PURA VIDA INVESTMENTS, LLC 对 MGX 的持仓历史
METAGENOMI THERAPEUTICS INC · 医疗保健
PURA VIDA INVESTMENTS, LLC 在 Q2 2026 的 13F 申报中披露持有 MGX(METAGENOMI THERAPEUTICS INC)264,391 股,市值约 US$315K,约占其申报组合的 0.85%,在其申报持仓中市值排名第 16 位。 PURA VIDA INVESTMENTS, LLC 最近 10 个申报季度中有 10 个季度披露了 MGX 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
PURA VIDA INVESTMENTS, LLC 对 MGX 的持仓演变
PURA VIDA INVESTMENTS, LLC 于 Q1 2024 首次披露 MGX 持仓:461,283 股(约 US$4.9M)。 在 10 次申报中,PURA VIDA INVESTMENTS, LLC 1 次增持、3 次减持、5 次保持不变。 最近一期申报(Q2 2026)显示持股 264,391 股、市值约 US$315K。 持仓曾出现大幅变动:Q2 2024 减持约 41% (随后一个季度股价下跌 12%)、Q2 2025 增持约 260% (随后一个季度股价上涨 60%)、Q3 2025 减持约 72% (随后一个季度股价下跌 32%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 461.28K | $4.87M | 新进 |
| Q2 2024 | 270.62K | $1.04M | 减持 |
| Q3 2024 | 270.62K | $587.24K | 持有 |
| Q4 2024 | 264.39K | $954.45K | 减持 |
| Q1 2025 | 264.39K | $359.57K | 持有 |
| Q2 2025 | 952.13K | $391.30K | 增持 |
| Q3 2025 | 264.39K | $626.61K | 减持 |
| Q4 2025 | 264.39K | $428.31K | 持有 |
| Q1 2026 | 264.39K | $354.28K | 持有 |
| Q2 2026 | 264.39K | $314.62K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MGX 与 13F 数据
MGX(METAGENOMI THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 23 只申报持有 MGX,申报仓位最大的包括:Catalio Capital Management, LP (US$630K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 PURA VIDA INVESTMENTS, LLC
常见问题
How long has PURA VIDA INVESTMENTS, LLC held MGX?
PURA VIDA INVESTMENTS, LLC has disclosed MGX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is PURA VIDA INVESTMENTS, LLC's current position in MGX?
As of Q2 2026, PURA VIDA INVESTMENTS, LLC holds 264.39K shares of MGX (METAGENOMI THERAPEUTICS INC), valued at $314.62K, representing 0.85% of its reported portfolio and ranking #16.
Has PURA VIDA INVESTMENTS, LLC been buying or selling MGX?
In the latest 13F filing (Q2 2026), PURA VIDA INVESTMENTS, LLC held unchanged its position in MGX.
Which other funds hold MGX?
Other major institutional holders of MGX include Catalio Capital Management, LP, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.